PUBLISHER: BIS Research | PRODUCT CODE: 1408631
PUBLISHER: BIS Research | PRODUCT CODE: 1408631
Europe Genomic Cancer Panel and Profiling Market: Analysis and Forecast, 2023-2033
“The Europe Genomic Cancer Panel and Profiling Market Expected to Reach $6.50 Billion by 2033.”
Introduction to Europe Genomic Cancer Panel and Profiling Market
As of 2023, the Europe genomic cancer panel and profiling market was valued at $2.64 billion and is expected to attain a value of $6.50 billion in 2033. The market is anticipated to grow at a CAGR of 9.42% during the forecast period 2023-2033. This growth is being driven by advances in genomic research and an increasing emphasis on precision therapy in oncology.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $2.64 Billion |
| 2033 Forecast | $6.50 Billion |
| CAGR | 9.42% |
Market Introduction
Genomic cancer panels and profiling are a contemporary technique to cancer detection that examines the genetic characteristics of malignancies before symptoms occur. The capacity of these panels to provide extensive genetic insights facilitates early detection and the development of tailored treatment strategies, which is a considerable advantage. The genomic cancer panel and profiling market is expanding because to the transformational potential these technologies have for changing cancer management. These panels improve our understanding of cancer genetics by allowing healthcare providers to identify particular genetic changes and customize interventions accordingly.
In the European market, genetic cancer panels and profiling are gaining popularity for cancer screening and management. These modern technologies provide detailed genetic information about malignancies, allowing for early detection and individualized treatment regimens. The demand for these panels is increasing as a result of their transformational potential in changing cancer management. Factors driving market expansion in Europe include the growing popularity of liquid biopsy testing, increased cancer risk due to lifestyle changes, and the need for early detection.
Market Segmentation
Segmentation 1: by Application
- Clinical
- Research
Segmentation 2: by End User
- Hospitals
- Clinical and Diagnostic Laboratories
- Research and Academic Institutes
- Other End Users
Segmentation 3: by Country
- U.K.
- France
- Italy
- Germany
- Spain
How can this report add value to an organization?
Product/Innovation Strategy: The Europe genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.
Table of Contents
Executive Summary
1. Markets
- 1.1. Market Scope
- 1.1.1. Key Questions Answered in this Report
- 1.2. Research Methodology
- 1.2.1. Genomic Cancer Panel and Profiling Market: Research Methodology
- 1.2.2. Data Sources
- 1.2.3. Market Estimation Model
- 1.2.4. Criteria for Company Profiling
- 1.3. Market Overview
- 1.3.1. Market Definition
- 1.3.2. Market Footprint and Growth Potential
- 1.3.3. Future Potential
2. Industry Analysis
- 2.1. Legal Requirements
- 2.1.1. Regulation of Genetic Tests
- 2.1.2. NCCN Guidelines
- 2.1.3. Reimbursement Scenario
- 2.2. Patent Analysis
- 2.2.1. Patent Filing Trend
- 2.2.2. Patent Analysis (by Year)
- 2.2.3. Patent Analysis (by Country)
3. Market Dynamics
- 3.1. Overview
- 3.1.1. Impact Analysis
- 3.2. Market Drivers
- 3.2.1. Rising Need for Cancer Profiling in Developed Countries Driving Demand for Genomic Panels and Profiling Tests
- 3.2.2. Increase in Genomic Research Funding Expanding the Market for Genomic Cancer Panels and Profiling
- 3.2.3. Technological Advancements in the Field of Informatics Expanding Consumer Reach
- 3.3. Market Restraints
- 3.3.1. Significant Implications of Reimbursement Reductions Impacting Growth of the Genomic Cancer Panel and Profiling Market
- 3.3.2. Impact of High-Cost Pressure Hindering Development in Genomic Cancer Panel and Profiling Testing
- 3.4. Market Opportunities
- 3.4.1. Robust Pipeline of Genomic Cancer Panels and Profiling Tests Poised to Revolutionize Cancer Diagnosis
- 3.4.2. Discovery of New Biomarkers Presents an Opportunity for the Development of Diagnostics Tools and Technologies
4. Competitive Insights
- 4.1. Overview
- 4.2. Key Strategies and Developments
- 4.2.1. Product Launches, Approvals, and Upgradations
- 4.2.2. Synergistic Activities
- 4.2.3. Mergers and Acquisitions
- 4.2.4. Business Expansions, Funding, and Licenses
- 4.3. Growth-Share Analysis
- 4.3.1. Growth-Share Analysis (by Technology), 2022
5. By Region
- 5.1. Overview
- 5.2. Europe
- 5.2.1. Key Dynamics
- 5.2.2. Germany
- 5.2.3. France
- 5.2.4. U.K.
- 5.2.5. Italy
- 5.2.6. Spain
- 5.2.7. Rest-of-Europe
6. Company Profiles
- 6.1. Overview
- 6.2. F. Hoffmann-La Roche Ltd
- 6.2.1. Company Overview
- 6.2.2. Role of F. Hoffmann-La Roche Ltd in the Genomic Cancer Panel and Profiling Market
- 6.2.3. Corporate Strategies
- 6.2.4. Business Strategies
- 6.2.5. Financials
- 6.2.6. Analyst Perspective
List of Figures
- Figure 1: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 2: Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
- Figure 3: Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
- Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
- Figure 5: Genomic Cancer Panel and Profiling Market: Research Methodology
- Figure 6: Primary Research Methodology
- Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
- Figure 8: Top-Down Approach (Segment-Wise Analysis)
- Figure 9: Genomic Cancer Panel and Profiling Workflow, End User Perspective
- Figure 10: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
- Figure 11: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 12: General Testing Criterion According to the NCCN Guidelines
- Figure 13: Reimbursement Components in the U.S.
- Figure 14: Genomic Cancer Panel and Profiling Market, Patent Analysis (by Year), January 2020-October 2023
- Figure 15: Genomic Cancer Panel and Profiling Market, Patent Analysis (by Country), January 2020-October 2023
- Figure 16: Genomic Cancer Panel and Profiling Market Dynamics
- Figure 17: Cancer Profiling Cases in Developed Countries
- Figure 18: Share of Global Cancer Prevalence, 2010-2019
- Figure 19: Share of Global Age-Standardized Death Rate of Cancer, 2010-2019
- Figure 20: Genomic Research Funding by National Human Genome Research Institute (NHGRI), $Million, 2020, 2021, and 2022
- Figure 21: Key Players Offering
- Figure 22: Reimbursement Reductions Adopted for Oncology Testing as per PAMA Revisions
- Figure 23: Cost Difference between the Multi-Gene Panel Test and Usual Care Screening Test
- Figure 24: Share of Key Developments, January 2020-October 2023
- Figure 25: Number of Product Launches, Approvals, and Upgradations (by Company), January 2020-October 2023
- Figure 26: Growth-Share Analysis of the Genomic Cancer Panel and Profiling Market (by Technology), 2022
- Figure 27: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
- Figure 28: Europe Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 29: Europe Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
- Figure 30: Europe Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
- Figure 31: Europe Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
- Figure 32: Germany Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 33: France Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 34: U.K. Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 35: Italy Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 36: Spain Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 37: Rest-of-Europe Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
- Figure 38: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
- Figure 39: F. Hoffmann-La Roche Ltd: Product Portfolio
- Figure 40: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2020-2022
- Figure 41: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2020-2022
- Figure 42: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2020-2022
List of Tables
- Table 1: Genomic Cancer Panel and Profiling Market, Impact Analysis
- Table 2: Technological Trends in the Genomic Cancer Panel and Profiling Market
- Table 3: Genomic Cancer Panel and Profiling Market, Impact Analysis
- Table 4: Genomic Cancer Panel and Profiling Market, Pipeline Tests
- Table 5: Ongoing Cancer-Based Biomarkers Trials
- Table 6: Europe Genomic Cancer Panel and Profiling Market, Impact Analysis
